ClinicalTrials.Veeva

Menu

Prevalance Of Helicobacter Pylori Infection In Chonic Kidney Diseased Patient Admitted To Luxor Medical Complex

A

Assiut University

Status

Not yet enrolling

Conditions

Chronic Kidney Diseases

Treatments

Other: disease

Study type

Observational

Funder types

Other

Identifiers

NCT06371001
Helicobacter Pyloi and CKD

Details and patient eligibility

About

Detect prevalence of Helicobacter pylori infection in chronic kidney diseased patient admitted to Luxor medical complex and possible role of Helicobacter pylori in pathogenesis of chronic kidney diseased patient of unknown etiology

Full description

Helicobacter Pylori bacteria is the main pathogenic organism that settles on the gastric mucosa of more than half the human population around the world, with more prominence in the developing countries. H. Pylori had been found to be the main factor in acute and chronic gastritis, peptic ulcer diseases, and in most cases gastric malignancy. Beside to some extra gastro-intestinal diseases. Such as cardiac, pulmonary, renal and hematological diseases.

Another study showed a significant higher proteinuria in H. Pylori infected patients compared to non-infected individuals. Helicobacter pylori is a gram-negative bacterium infecting both children and adults. It is the most common human chronic infection, causing gastrointestinal diseases such as gastric malignancies, gastritis, and ulcerative diseases. H. pylori can also be involved in other non gastrointestinal infections such as diabetes and metabolic syndrome, heart disease, hematologic disorders, cancer, and chronic kidney disease (CKD) as well as chronic renal failure (CRF).

Some chronic renal failure patients who have received hemodialysis for long periods complained of gastrointestinal troubles. It has been postulated that high urea concentration makes the gastric mucosa of these patients more susceptible to H. pylori colonization. Previous observations in different countries reported the prevalence of H. pylori infection among patients with CRF ranging between 20 and 60%, and H. pylori infection can contribute to progressive renal dysfunction resulting in CKD development. In patients without established gastric dysfunction, the presence of H pylori infection was associated with increased risk for Chronic kidney dusease however, patients with both atrophic gastritis (AG) and Helcobacter pylori infection appeared to be at decreased risk for Chronic kidney disease compared with control participants.

For the H. pylori-positive patients with peptic ulcer, H. pylori infection may be a risk factor resulting in kidney damage and H. pylori eradication probably benefits to kidney damage relief and chronic kidney disease prevention.

Enrollment

122 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients aged >18 years old with chronic kidney disease of different etiology based on clinical examination, laboratory investigations and imaging

Exclusion criteria

  1. Patients aged ≤18 years old.
  2. Overloaded patients
  3. patient with acute kidney injury
  4. Patients with other GIT disease
  5. pregnant female
  6. patient taking aspirin, NSAID, steroid or antibiotic
  7. Presence of malignancy

Trial design

122 participants in 2 patient groups

prevalence of helicobacter pylori in chronic kidney diseased patient
Description:
prevalence of helicobacter pylori in chronic kidney diseased patient
Treatment:
Other: disease
prevalence of helicobacter pylori in non chronic kidney diseased patient
Description:
prevalence of helicobacter pylori in non chronic kidney diseased patient
Treatment:
Other: disease

Trial contacts and locations

0

Loading...

Central trial contact

Mohammed Abaas, professor; Gehad Abdel shafy, Resident

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems